Do collagen peptides help joint pain?
Probably a little for some people with knee osteoarthritis. The overall randomized-trial signal favors collagen for pain and function. The evidence is not clean enough to promise a large effect, and it does not show that a supplement rebuilds worn cartilage.
- Evidence base
- An updated review combined 11 randomized trials and 870 participants.
- Overall direction
- Pain and function scores favored collagen over placebo.
- Main limitation
- Products, outcome measures, and study results varied substantially.
Why collagen belongs in the conversation
Collagen is less dramatic than the injectable “healing peptide” market. It is also better studied. For older readers seeking a relatively simple, nonprescription option, that makes the evidence worth understanding—even if the likely benefit is modest.
What the reviews found
A 2025 meta-analysis of 11 randomized controlled trials reported improvements in pain and function. A 2023 analysis of four trials and 507 people also found pain relief, but every included trial was judged at high risk of bias and results varied considerably.
A newer 180-day randomized trial in 80 adults with mild knee osteoarthritis found better pain and function scores with a specific low-molecular-weight collagen product, but no meaningful change in joint-space width or inflammatory markers. Symptom improvement is not the same as structural repair.
The product problem
“Collagen” can mean hydrolyzed collagen peptides, gelatin, or undenatured type II collagen. A positive trial on one preparation does not automatically validate every tub on a store shelf. Supplements also are not reviewed by FDA for effectiveness before sale in the same way approved drugs are.
Our verdict: Collagen peptides have a more credible human signal than BPC-157 or TB-500 for knee-arthritis symptoms. Keep the expectation grounded: possible symptom relief, not proof of cartilage regeneration and not a substitute for identifying the type and drivers of joint pain.
Primary sources
- Updated systematic review and meta-analysis (11 randomized trials; 870 participants)
- Analgesic efficacy meta-analysis (four randomized trials; 507 participants)
- 2025 randomized placebo-controlled trial (80 participants)
Last reviewed August 11, 2026. This page does not recommend a brand, product, or dose.